Serina Therapeutics Inc (SER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 130 | 56 | 3,153 | 34 | 144 |
| Cost of Goods | N/A | N/A | N/A | 13 | 19 |
| Gross Profit | 130 | 56 | 3,153 | 21 | 125 |
| Operating Expenses | 24,152 | 17,104 | 6,282 | 7,009 | 8,077 |
| Operating Income | -24,022 | -17,048 | -3,129 | -6,975 | -7,933 |
| Interest Expense | 213 | 526 | 558 | 3,335 | 1,097 |
| Other Income | 5,038 | 6,367 | 8,956 | -212 | 448 |
| Pre-tax Income | -19,197 | -11,207 | 5,269 | -10,522 | -8,582 |
| Income Tax | 18 | N/A | 0 | N/A | N/A |
| Net Income Continuous | -19,215 | -11,207 | 5,269 | -10,522 | -8,582 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -103 |
| Minority Interests | -33 | -66 | N/A | -60 | -10 |
| Net Income | $-19,182 | $-11,141 | $5,269 | $-10,462 | $-8,675 |
| EPS Basic Total Ops | -1.91 | -1.51 | 2.36 | -9.70 | -8.10 |
| EPS Basic Continuous Ops | -1.89 | -1.52 | 2.36 | -9.75 | -7.98 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -0.10 |
| EPS Diluted Total Ops | -1.91 | -1.51 | 0.73 | -9.70 | -8.10 |
| EPS Diluted Continuous Ops | -1.89 | -1.52 | 0.72 | -9.75 | -7.98 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -0.10 |
| EPS Diluted Before Non-Recurring Items | -1.91 | -1.51 | -13.72 | -9.86 | -8.10 |
| EBITDA(a) | $-23,891 | $-16,509 | $-3,039 | $-3,706 | $-6,688 |